252 related articles for article (PubMed ID: 29748743)
41. The protective effect of lactoferrin on ventral mesencephalon neurons against MPP + is not connected with its iron binding ability.
Wang J; Bi M; Liu H; Song N; Xie J
Sci Rep; 2015 Jun; 5():10729. PubMed ID: 26035688
[TBL] [Abstract][Full Text] [Related]
42. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats.
Sola A; Rogido M; Lee BH; Genetta T; Wen TC
Pediatr Res; 2005 Apr; 57(4):481-7. PubMed ID: 15718373
[TBL] [Abstract][Full Text] [Related]
43. Apo- and holo-lactoferrin stimulate proliferation of mouse crypt cells but through different cellular signaling pathways.
Jiang R; Lönnerdal B
Int J Biochem Cell Biol; 2012 Jan; 44(1):91-100. PubMed ID: 22009034
[TBL] [Abstract][Full Text] [Related]
44. Erythropoietin activates Keap1-Nrf2/ARE pathway in rat brain after ischemia.
Meng H; Guo J; Wang H; Yan P; Niu X; Zhang J
Int J Neurosci; 2014 May; 124(5):362-8. PubMed ID: 24063261
[TBL] [Abstract][Full Text] [Related]
45. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.
Brines ML; Ghezzi P; Keenan S; Agnello D; de Lanerolle NC; Cerami C; Itri LM; Cerami A
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10526-31. PubMed ID: 10984541
[TBL] [Abstract][Full Text] [Related]
46. Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220.
Lee JA; Son HJ; Choi JW; Kim J; Han SH; Shin N; Kim JH; Kim SJ; Heo JY; Kim DJ; Park KD; Hwang O
Neurochem Int; 2018 Jan; 112():96-107. PubMed ID: 29158022
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the bioactivity of recombinant human lactoferrins toward murine osteoblast-like cells for bone tissue engineering.
Amini AA; Nair LS
Tissue Eng Part A; 2013 May; 19(9-10):1047-55. PubMed ID: 23270517
[TBL] [Abstract][Full Text] [Related]
48. 28-day repeated dose oral toxicity of recombinant human holo-lactoferrin in rats.
Cerven D; DeGeorge G; Bethell D
Regul Toxicol Pharmacol; 2008 Nov; 52(2):174-9. PubMed ID: 18700160
[TBL] [Abstract][Full Text] [Related]
49. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin.
Liu J; Narasimhan P; Yu F; Chan PH
Stroke; 2005 Jun; 36(6):1264-9. PubMed ID: 15890996
[TBL] [Abstract][Full Text] [Related]
50. Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth.
Huang N; Bethell D; Card C; Cornish J; Marchbank T; Wyatt D; Mabery K; Playford R
In Vitro Cell Dev Biol Anim; 2008; 44(10):464-71. PubMed ID: 18802738
[TBL] [Abstract][Full Text] [Related]
51. CHO expressed recombinant human lactoferrin as an adjuvant for BCG.
Hwang SA; Kruzel ML; Actor JK
Int J Immunopathol Pharmacol; 2015 Dec; 28(4):452-68. PubMed ID: 26315722
[TBL] [Abstract][Full Text] [Related]
52. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia.
Yang C; Zhang X; Fan H; Liu Y
Brain Res; 2009 Jul; 1282():133-41. PubMed ID: 19445907
[TBL] [Abstract][Full Text] [Related]
53. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin.
Prass K; Scharff A; Ruscher K; Löwl D; Muselmann C; Victorov I; Kapinya K; Dirnagl U; Meisel A
Stroke; 2003 Aug; 34(8):1981-6. PubMed ID: 12829864
[TBL] [Abstract][Full Text] [Related]
54. C-terminal mechano-growth factor induces heme oxygenase-1-mediated neuroprotection of SH-SY5Y cells via the protein kinase Cϵ/Nrf2 pathway.
Quesada A; Ogi J; Schultz J; Handforth A
J Neurosci Res; 2011 Mar; 89(3):394-405. PubMed ID: 21259326
[TBL] [Abstract][Full Text] [Related]
55. Z-ligustilide activates the Nrf2/HO-1 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro.
Peng B; Zhao P; Lu YP; Chen MM; Sun H; Wu XM; Zhu L
Brain Res; 2013 Jul; 1520():168-77. PubMed ID: 23688544
[TBL] [Abstract][Full Text] [Related]
56. Derivatives of erythropoietin that are tissue protective but not erythropoietic.
Leist M; Ghezzi P; Grasso G; Bianchi R; Villa P; Fratelli M; Savino C; Bianchi M; Nielsen J; Gerwien J; Kallunki P; Larsen AK; Helboe L; Christensen S; Pedersen LO; Nielsen M; Torup L; Sager T; Sfacteria A; Erbayraktar S; Erbayraktar Z; Gokmen N; Yilmaz O; Cerami-Hand C; Xie QW; Coleman T; Cerami A; Brines M
Science; 2004 Jul; 305(5681):239-42. PubMed ID: 15247477
[TBL] [Abstract][Full Text] [Related]
57. Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats.
Merelli A; Caltana L; Girimonti P; Ramos AJ; Lazarowski A; Brusco A
Neurotox Res; 2011 Aug; 20(2):182-92. PubMed ID: 21116766
[TBL] [Abstract][Full Text] [Related]
58. [Animal experiment of recombinant human lactoferrin based on the 28 days repeated oral toxicity].
Ma B; Yuan X; Wang X; Gao P; Zhao Z; Yang J; Peng S; Xu H
Wei Sheng Yan Jiu; 2017 May; 46(3):443-454. PubMed ID: 29903257
[TBL] [Abstract][Full Text] [Related]
59. Lactoferrin, a Critical Player in Neonate Intestinal Development: RHLF may be a Good Choice in Formula.
Wang W; Cheng Z; Wang X; An Q; Huang K; Dai Y; Meng Q; Zhang Y
J Agric Food Chem; 2021 Aug; 69(31):8726-8736. PubMed ID: 34323077
[TBL] [Abstract][Full Text] [Related]
60. Nrf2 activation in the liver of rats subjected to a preconditioning sub-chronic iron protocol.
Morales P; Vargas R; Videla LA; Fernández V
Food Funct; 2014 Feb; 5(2):243-50. PubMed ID: 24346829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
